Molecular mechanisms orchestrating intratumoral heterogeneity in Kras-driven carcinomas

被引：0
|
作者：
Azimi, Roxana
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2403
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Unfolding the role of cell state on stress granule heterogeneity and function in KRAS-driven pancreatic cancer
    Redding, Alexandra
    Fonteneau, Guillaume
    Grabocka, Elda
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [12] Developing combinatorial therapies for KRAS-driven cancers
    Cichowski, Karen
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [13] CREB is required for KRAS-driven lung tumorigenesis
    Lee, Jong Woo
    Slack, Frank J.
    Nestler, Eric J.
    Herbst, Roy S.
    Koo, Jaseok Peter
    CANCER RESEARCH, 2018, 78 (13)
  • [14] Metabolic vulnerability of KRAS-driven cancer cells
    Foster, David A.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (03):
  • [15] Targeting the MAPK Pathway in KRAS-Driven Tumors
    Drosten, Matthias
    Barbacid, Mariano
    CANCER CELL, 2020, 37 (04) : 543 - 550
  • [16] PKCε Is Required for KRAS-Driven Lung Tumorigenesis
    Garg, Rachana
    Cooke, Mariana
    Benavides, Fernando
    Abba, Martin C.
    Cicchini, Michelle
    Feldser, David M.
    Kazanietz, Marcelo G.
    CANCER RESEARCH, 2020, 80 (23) : 5166 - 5173
  • [17] Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit
    Theodora Katopodi
    Savvas Petanidis
    Kalliopi Domvri
    Paul Zarogoulidis
    Doxakis Anestakis
    Charalampos Charalampidis
    Drosos Tsavlis
    Chong Bai
    Haidong Huang
    Lutz Freitag
    Wolfgang Hohenforst-Schmidt
    Dimitris Matthaios
    Konstantinos Porpodis
    Scientific Reports, 11
  • [18] Targeting metabolic reprogramming in KRAS-driven cancers
    Kawada, Kenji
    Toda, Kosuke
    Sakai, Yoshiharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (04) : 651 - 659
  • [19] Targeting cytokine networks in KRAS-driven tumorigenesis
    Golay, Hadrien G.
    Barbie, David A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (08) : 869 - 871
  • [20] Targeting metabolic reprogramming in KRAS-driven cancers
    Kenji Kawada
    Kosuke Toda
    Yoshiharu Sakai
    International Journal of Clinical Oncology, 2017, 22 : 651 - 659
12345